Work

Phase II multicenter pilot study of safety, efficacy, and immune cell profiling in advanced hepatocellular carcinoma (HCC) on combination of sorafenib (SOR) plus nivolumab (NIVO).

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.4_suppl.tps464

Authors: Bridget Keenan, Madeline J Griffith, Kelly Bauer, Paige M. Bracci, Spencer Behr, Sarah E Umetsu, John Dozier Gordan, Zoe Ngo, Syma Iqbal, Diana L. Hanna, Alan P. Venook, Anthony B. El-Khoueiry, Lawrence Fong, Robin Kate Kelley

Institutions: University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, University of Southern California, USC Norris Comprehensive Cancer Center

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2914094937

Cites:

Cited by: 2

Related to: 10